Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "M-M-R II Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering.
The M-M-R II market is witnessing significant growth driven by key factors including expanded health insurance coverage, increased focus on preventive healthcare, and heightened public awareness about vaccine safety. The market's expansion is attributed to the growing demand for convenient vaccination services and the increased need for travel vaccines. Enhanced awareness of waning immunity, efforts to counter vaccine hesitancy, and the adoption of telemedicine further escalate market growth prospects.
Emerging trends during the forecast period include the development of combination vaccines, advancements in pharmaceutical innovation, and thermostable vaccine formulations. There is also a growing trend towards adopting digital immunization records and improving cold chain technology. The rising incidences of measles, mumps, and rubella, all highly contagious diseases, play a crucial role in amplifying the demand for the M-M-R II vaccine. For instance, the UK Health Security Agency reported a surge in mumps and measles cases, leading to increased vaccination rates.
Successful vaccination programs organized by governments and health organizations contribute significantly to the market's growth. These initiatives benefit from public awareness, effective distribution systems, and strong governmental support. Vaccination programs improve public health by significantly reducing the incidence of measles, mumps, and rubella, thereby boosting the market for the M-M-R II vaccine. During the 2022-2023 school-aged vaccination program, over 3.5 million children were vaccinated in the UK, reflecting the continued success and importance of these programs.
Innovative therapies, such as live attenuated vaccines, are a key trend in the M-M-R II market, enhancing immunization effectiveness and broadening protection against measles, mumps, and rubella. Notably, Merck & Co. Inc. received FDA approval in March 2023 for the intramuscular administration of the M-M-R II vaccine, which remains a crucial preventive measure for these diseases in individuals aged 12 months and older.
Geographically, North America was the largest region in the M-M-R II market as of 2024, with Asia-Pacific poised to experience the fastest growth. Regions covered in this analysis include Asia-Pacific, Western Europe, Eastern Europe, North America, and others. Countries under review comprise Australia, Brazil, China, France, Germany, India, Japan, and several others.
The market consists of sales of vaccines such as single antigen vaccines, ProQuad, Priorix, and Ruvax, with values captured at the 'factory gate'-the point of manufacturing or creation. The reported market revenues reflect consumption values generated within specified geographies, focusing on goods and services produced in these regions.
In summary, the M-M-R II market continues to grow by integrating strategic developments and responding to emerging public health trends. Continuous innovations, combined with effective government and health organization initiatives, ensure the market's prosperity and improved global health outcomes by mitigating the risks posed by measles, mumps, and rubella.
Key Topics Covered:
1. Executive Summary
2. M-M-R II Market Characteristics
3. M-M-R II Market Biologic Drug Characteristics
- 3.1. Molecule Type
- 3.2. Route of Administration (ROA)
- 3.3. Mechanism of Action (MOA)
- 3.4. Safety and Efficacy
4. M-M-R II Market Trends and Strategies
5. M-M-R II Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market
6. Global M-M-R II Growth Analysis and Strategic Analysis Framework
- 6.1. Global M-M-R II PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 6.2. Analysis of End Use Industries
- 6.3. Global M-M-R II Market Growth Rate Analysis
- 6.4. Global M-M-R II Historic Market Size and Growth, 2019-2024, Value ($ Million)
- 6.5. Global M-M-R II Forecast Market Size and Growth, 2024-2029, 2034F, Value ($ Million)
- 6.6. Global M-M-R II Total Addressable Market (TAM)
7. Global M-M-R II Pricing Analysis & Forecasts
8. M-M-R II Market Segmentation
- 8.1. Global M-M-R II Market, Segmentation by Indication
- 8.2. Global M-M-R II Market, Segmentation by Formulation
- 8.3. Global M-M-R II Market, Segmentation by Distribution Channel
- 8.4. Global M-M-R II Market, Segmentation by End User Patients
9. Global M-M-R II Epidemiology of Clinical Indications
- 9.1. Drug Side Effects
- 9.2. Incidence and Prevalence of Clinical Indications
10. M-M-R II Market Regional and Country Analysis
- 10.1. Global M-M-R II Market, Split by Region
- 10.2. Global M-M-R II Market, Split by Country
For more information about this report visit https://www.researchandmarkets.com/r/23sy4y
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
